A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manicdepressive psychosis

Biological Psychiatry

Volumn 21, Issue 10, 1986, Pages 915-920

  Naylor, G J ^a   Martin, B ^a   Hopwood, S E ^a   Watson, Y ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; METHYLENE BLUE; PLACEBO;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MIXTURE; DRUG THERAPY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; THERAPY;

BIPOLAR DISORDER; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMAN; LONG-TERM CARE; METHYLENE BLUE; PSYCHIATRIC STATUS RATING SCALES; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T;

EID: 0022552935     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(86)90265-9     Document Type: Article

References (13)

1. The use of methylene blue in the treatment of catatonic dementia praecox patients
2. La bleu de methylene comme calmant chez les alienes
3. The fate of cytoplasmic vanadium
4. A double blind comparison of lithium carbonate and marprotiline in the prophylaxis of the affective disorders
5. Die Wirkung von Methylenblau
6. A double blind crossover trial comparing the prophylactic action of flupenthixol with placebo
7. Methylene blue: A possible treatment for manic depressive psychosis
8. Vanadium, a possible aetiological factor in manic depressive illness
9. Methylene blue. A new treatment for manic depressive psychosis
10. Catalysis of reduction of vanadate by psychotropic drugs
11. Tissue vanadium levels in manic depressive psychosis
12. Interpretation of the psychostimulating effect of methylene blue
13. Methylene blue in treatment of bipolar illness